Glycomet Trio 2 Tablet

• Glycomet Trio 2 Tablet SR is used in the treatment of type 2 diabetes

• Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them Common side effects of Glycomet Trio Nausea Diarrhea Abdominal pain Hypoglycemia (low blood glucose level) Loss of appetite

If you experience any persistent or severe side effects, consult your doctor immediately.

• Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Glycomet Trio 2 Tablet SR is to be taken with food.

• How Glycomet Trio Tablet SR works Glycomet Trio 2 Tablet SR is a combination of three antidiabetic medicines: glimepiride, metformin, and voglibose. They work by different mechanisms to provide better control of blood sugar when single or dual therapy is not effective. Glimepiride is a sulfonylurea that works by increasing the amount of insulin released by the pancreas to lower the blood glucose. Metformin is a biguanide that lowers glucose production in the liver, delays glucose absorption from the intestines, and increases the body's sensitivity to insulin. Voglibose is an alpha-glucosidase inhibitor that prevents the breakdown of complex sugars into simple sugars such as glucose. This prevents the blood glucose levels from rising to very high levels after meals.

• 
  Alcohol:

  It is unsafe to consume alcohol with Glycomet Trio 2 Tablet SR.

• 
  Driving:

  Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.

• 
  Kidney:

  Glycomet Trio 2 Tablet SR is probably unsafe to use in patients with kidney disease and should be avoided. Please consult your doctor. Use of Glycomet Trio 2 Tablet SR is, however, not recommended in patients with severe kidney disease.

• 
  Liver:

  Glycomet Trio 2 Tablet SR should be used with caution in patients with liver disease. Dose adjustment of Glycomet Trio 2 Tablet SR may be needed. Please consult your doctor. Glycomet Trio 2 Tablet SR is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.

• 
  Pregnancy:

  Glycomet Trio 2 Tablet SR may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.

• 
  Breastfeeding:

  Glycomet Trio 2 Tablet SR is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.